
Home » Prescription Drugs 3 » BETAGLIM Amaryl
Glimepiride is an anti-diabetic drug (sulfonylurea-type) used along with a proper diet and exercise program to control high blood sugar. It is used in patients with type 2 diabetes (non-insulin-dependent diabetes). It works by stimulating the release of your body's natural insulin. Effectively controlling high blood sugar helps prevent heart disease strokes kidney disease blindness and circulation problems as well as sexual function problems (impotence).How to use Glimepiride OralTake this medication by mouth usually once daily with breakfast or the first main meal of the day. The dosage is based on your medical condition and response to therapy.Use this medication regularly in order to get the most benefit from it. To help you remember use it at the same time each day. Monitor blood glucose levels on a regular basis and share the results with your doctor.
Buy BETAGLIM Amaryl and other Prescription Drugs 3 products online
at Medstore.
Buy Online at Medstore - Click Here!

About BETAGLIM Amaryl:
Product Type: Prescription Drugs 3
BETAGLIM ( Amaryl Generic Glimepiride )
BETAGLIM (Amaryl Generic Glimepiride)
Amaryl Generic Glimepiride
3mg Tabs 30 ( 3 x 10) 4mg Tabs
Amaryl Generic Glimepiride BETAGLIM

View more
Prescription Drugs 3
Previous Product Next Product
Pharmacy:
Dozens of patents for name-brand drugs are due to expire within the next 14 months, and generic drugs will replace some of the most popular and widely advertised drugs used today. For millions of people worldwide, this means switching from familiar brands like Lipitor to generic equivalents. How will this affect drug companies, and what will be the impact on people who depend on expensive prescription medication? Here, a brief guide:
Which drugs are scheduled to go generic?
Some real blockbusters. "In the next two years, six of the 10 top-selling drugs will lose their patents," says Chris Woolston in the Los Angeles Times. Lipitor, the world's best-selling drug, which is used to lower cholesterol, will be available as a generic in November of this year. Another best-seller, the blood thinner Plavix, will lose its patent in May 2012. Other well-known drugs with expiring patents include the arthritis treatment Enbrel, the anti-psychotic Zyprexa, as well as drugs for bipolar disorder, HIV, high cholesterol, and other conditions.


|